Indaco Venture Partners — 2022 Investments

2 investments dated 2022 · listed companies and verified rows first · show all

InnovHeartinnovheart.comJan 2022 · $55M

InnovHeart develops the Saturn Transcatheter Mitral Valve Replacement (TMVR) system, a trans-septal mitral valve bioprosthesis used in interventional cardiology to treat mitral valve disease.

HealthtechMedical Devices

David James Wilson(Chief Executive Officer)

Co-investorsCDP Venture Capital Panakes Partners

Sibyllasibyllabiotech.it in 𝕏Oct 2022

Sibylla Biotech develops PPI-FIT, a drug discovery technology that uses quantum physics and mathematical modeling to characterize protein folding pathways at atomic resolution.

AI & Machine LearningBiotechDeep TechTrento, IT

Emiliano Biasini(Co-founder)in Pietro Faccioli(Co-founder)inGiovanni Spagnolli(Co-founder, CTO)in Maria Letizia Barreca(Co-founder)inGraziano Lolli(Co-founder)

Co-investors3B Future Health Fund CDP Venture Capital Seroba Life Sciences V-Bio Ventures Vertis SGR VI Partners +1 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.